The impact of tau on cognition is also dramatically illustrated in an AD individual homozygous for the Christchurch mutation in APOE, which presented low levels of tauopathy and absence of dementia even when displaying an advanced brain amyloidosis [3, 24, 53, 93]. The gene discussed is MAPT; the disease is Alzheimer disease.